Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
European Journal of Medicinal Chemistry|November 25, 2015
3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progressionPietro Rizza, Michele Pellegrino, Anna Caruso, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2014
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatmentCédric Lecoutey, Damien Hedou, Thomas Freret, et al.
International Journal of Particle Therapy|January 5, 2026
Radiobiology Contributions and Perspectives in Hadron Therapy, With a Focus on Carbon Ions: Report From the Workshop Hadron Therapy for Life, Caen, March 2025Siamak Haghdoost, Juliette Thariat, Iuliana Toma-Dasu, et al.
European Journal of Medicinal Chemistry|October 25, 2024
Synthesis, in vitro and in vivo biological evaluation of novel dual compounds targeting both acetylcholinesterase and serotonergic 5-HT<sub>4</sub> receptors with potential interest in the treatment of Alzheimer's diseaseChristophe Rochais, Cédric Lecoutey, Julien Lalut, et al.
Journal of Medicinal Chemistry|March 21, 2015
Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecoprideChristophe Rochais, Cédric Lecoutey, Florence Gaven, et al.
Nature Communications|May 16, 2024
Dynamic microfluidic single-cell screening identifies pheno-tuning compounds to potentiate tuberculosis therapyMaxime Mistretta, Mena Cimino, Pascal Campagne, et al.
International Journal of Molecular Sciences|April 14, 2026
Polyfunctionalized <i>N</i>-Arylsulfonyl Indoles: Identification of (<i>E</i>)-<i>N</i>-Hydroxy-3-{3-[(5-(3-(piperidin-1-yl)propoxy]-1<i>H</i>-indol-1-yl)sulfonyl]phenyl}acrylamide (MTP150) for the Epigenetic-Based Therapy of Parkinson's DiseaseMireia Toledano-Pinedo, Alicia Porro-Pérez, Linda Schäker-Hübner, et al.
Pageof 7